Levonorgestrel And Ethinyl Estradiol And Ethinyl Estradiol Kit
Product Images NDC 0378-7316

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Levonorgestrel And Ethinyl Estradiol And Ethinyl Estradiol (NDC 0378-7316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (2bb5d4df 72a9 4f35 80c1 D3634327b14a 01)

This appears to be a table showing the percentage of bleeding or spotting experienced at various points during a menstrual cycle. The cycles are divided into different lengths of time, and there are different percentages of bleeding or spotting for each cycle length. However, the output does not provide any additional context regarding what the data actually represents or what it is for.*

FDA Label Image

Figure (2bb5d4df 72a9 4f35 80c1 D3634327b14a 04)

Not available. The text contains many misspelled and incomplete words, making it difficult to decipher.*

FDA Label Image

Structural Formula (Image 01)

Levonorgestrel is a medication used as a type of emergency contraception. CaMal is a term that is not recognizable or understandable. MW 3124 might be referring to the molecular weight of the compound which is 312.4 g/mol.*

FDA Label Image

Image 02

This appears to be a chemical compound, specifically a combination of ethinyl and estradiol. The molecular weight of the compound is 2964.*

FDA Label Image

Image 03

FDA Label Image

Image 04

FDA Label Image

Image 05

FDA Label Image

Image 06

This appears to be a description of Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets. The tablets come in different dosages, as indicated in the text, and are intended to be dispensed by a pharmacist with a prescription. The blister cards should not be separated from the drug product, and each pouch contains one extended tablet or a pack of 91 tablets. Otherwise, the text is difficult to read due to errors.*

FDA Label Image

Image 07

This is a collection of scientific studies that compared the risk of certain health outcomes between women who have ever used combined oral contraceptives (COC) and those who have never used them. The studies were conducted in different countries and have different outcomes measures such as odds ratios, hazard ratios, or relative risk ratios. The studies provide estimates of the effect and confidence intervals around those estimates. The last line seems to depict a range of numbers that are not related to the text and may be an error.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.